摘要
目的:评价碳酸钙泡腾颗粒的人体生物利用度。方法:以原子吸收光谱法测定10名健康志愿者口服碳酸钙泡腾颗粒与进口碳酸钙片后的尿钙浓度,以尿钙总排泄量与尿钙增量为指标评价两种制剂吸收差异。结果:口服1.2g碳酸钙泡腾颗粒与碳酸钙片后4h尿钙总排泄量分别为0.143mg·(mgCr)-1与0.109mg·(mgCr)-1;尿钙增量分别为0.051mg·(mgCr)-1与0.031mg·(mgCr)-1,前者均显著高于后者(P<0.05和P<0.01)。结论:碳酸钙泡腾颗粒的口服生物利用度高于碳酸钙片。
Objective:To investigate the bioavailability of calcium carbonate effervescent granules in healthy volunteers.Methods:The urinary calcium were determined by atomic absorption spectrophotometry after a single oral dose of calcium carbonate effervescent granules and calcium carbonate tablet was given to 10 healthy volunteers.Results:The urinary calcium following calcium carbonate effervescent granules was significantly higher whether expressed as the total amount or as the increment above basal (fasting) excretion.Conclusion:The bioavailability of calcium carbonate effervescent granules was higher than calcium carbonate tablet.
出处
《中国医院药学杂志》
CAS
CSCD
北大核心
1998年第12期533-535,共3页
Chinese Journal of Hospital Pharmacy
关键词
碳酸钙泡腾颗粒
生物利用度
补钙剂
calcium carbonate,effervescent granules,bioavailability